171 related articles for article (PubMed ID: 20394635)
1. Outcomes of renal transplantation in recipients with Wegener's granulomatosis.
Shen J; Gill J; Shangguan M; Sampaio MS; Bunnapradist S
Clin Transplant; 2011; 25(3):380-7. PubMed ID: 20394635
[TBL] [Abstract][Full Text] [Related]
2. Kidney transplant outcomes in patients with Fabry disease.
Shah T; Gill J; Malhotra N; Takemoto SK; Bunnapradist S
Transplantation; 2009 Jan; 87(2):280-5. PubMed ID: 19155985
[TBL] [Abstract][Full Text] [Related]
3. Duration of end-stage renal disease and kidney transplant outcome.
Goldfarb-Rumyantzev A; Hurdle JF; Scandling J; Wang Z; Baird B; Barenbaum L; Cheung AK
Nephrol Dial Transplant; 2005 Jan; 20(1):167-75. PubMed ID: 15546892
[TBL] [Abstract][Full Text] [Related]
4. The association between recipient alcohol dependency and long-term graft and recipient survival.
Gueye AS; Chelamcharla M; Baird BC; Nguyen C; Tang H; Barenbaum AL; Koford JK; Shihab F; Goldfarb-Rumyantzev AS
Nephrol Dial Transplant; 2007 Mar; 22(3):891-8. PubMed ID: 17172252
[TBL] [Abstract][Full Text] [Related]
5. Renal transplant in Wegener's granulomatosis compared to microscopic polyangiitis.
Geetha D; Haas M; Kraus ES; Rabb H; Seo P
J Rheumatol; 2010 Aug; 37(8):1705-8. PubMed ID: 20516028
[TBL] [Abstract][Full Text] [Related]
6. Renal transplantation outcomes: a comparative analysis between elderly and younger recipients.
Mendonça HM; Dos Reis MA; de Castro de Cintra Sesso R; Câmara NO; Pacheco-Silva A
Clin Transplant; 2007; 21(6):755-60. PubMed ID: 17988270
[TBL] [Abstract][Full Text] [Related]
7. Patient and graft outcomes from deceased kidney donors age 70 years and older: an analysis of the Organ Procurement Transplant Network/United Network of Organ Sharing database.
Chavalitdhamrong D; Gill J; Takemoto S; Madhira BR; Cho YW; Shah T; Bunnapradist S
Transplantation; 2008 Jun; 85(11):1573-9. PubMed ID: 18551062
[TBL] [Abstract][Full Text] [Related]
8. Race effects.
Koyama H; Cecka JM
Clin Transpl; 1991; ():269-80. PubMed ID: 1820122
[TBL] [Abstract][Full Text] [Related]
9. Favorable graft survival in renal transplant recipients with polycystic kidney disease.
Johnston O; O'Kelly P; Donohue J; Walshe JJ; Little DM; Hickey D; Conlon PJ
Ren Fail; 2005; 27(3):309-14. PubMed ID: 15957548
[TBL] [Abstract][Full Text] [Related]
10. Transplanting kidneys from CMV-seropositive donors to CMV-seronegative recipients is not associated with poorer renal allograft function or survival.
McLaughlin K; Sandhu S; Wu C; Muirhead N; Hollomby D; Jevnikar A
Nephrol Dial Transplant; 2005 Jan; 20(1):176-80. PubMed ID: 15572381
[TBL] [Abstract][Full Text] [Related]
11. The influence of pre-operative electrocardiographic abnormalities and cardiovascular risk factors on patient and graft survival following renal transplantation.
Woo YM; McLean D; Kavanagh D; Ward L; Aitken S; Miller GJ; Egan P; Hughes K; Clark L; Carswell K; Morris ST; Northridge DB; Rodger RS; Jardine AG
J Nephrol; 2002; 15(4):380-6. PubMed ID: 12243367
[TBL] [Abstract][Full Text] [Related]
12. Classical versus non-renal Wegener's granulomatosis.
Luqmani RA; Bacon PA; Beaman M; Scott DG; Emery P; Lee SJ; Howie AJ; Richards N; Michael J; Adu D
Q J Med; 1994 Mar; 87(3):161-7. PubMed ID: 8208904
[TBL] [Abstract][Full Text] [Related]
13. Long-term follow-up of renal transplantation for Wegener's disease.
Tzardis PJ; Gruessner RW; Matas AJ; Payne WD; Dunn DL; Sutherland DE; Najarian JS
Clin Transplant; 1990 Apr; 4(2):108-11. PubMed ID: 10147564
[TBL] [Abstract][Full Text] [Related]
14. Clinical outcome of interval cadaveric renal transplantation in cardiac allograft recipients.
Kuo PC; Luikart H; Busse-Henry S; Hunt SA; Valantine HA; Stinson EB; Oyer PE; Scandling JD; Alfrey EJ; Dafoe DC
Clin Transplant; 1995 Apr; 9(2):92-7. PubMed ID: 7599409
[TBL] [Abstract][Full Text] [Related]
15. Wegener's granulomatosis with renal involvement: patient survival and correlations between initial renal function, renal histology, therapy and renal outcome.
Andrassy K; Erb A; Koderisch J; Waldherr R; Ritz E
Clin Nephrol; 1991 Apr; 35(4):139-47. PubMed ID: 1855316
[TBL] [Abstract][Full Text] [Related]
16. The outcome of renal transplantation among systemic lupus erythematosus patients.
Chelamcharla M; Javaid B; Baird BC; Goldfarb-Rumyantzev AS
Nephrol Dial Transplant; 2007 Dec; 22(12):3623-30. PubMed ID: 17640941
[TBL] [Abstract][Full Text] [Related]
17. Risk variables associated with the outcome of kidney recipients >70 years of age in the new millennium.
Heldal K; Hartmann A; Leivestad T; Foss A; Midtvedt K
Nephrol Dial Transplant; 2011 Aug; 26(8):2706-11. PubMed ID: 21285131
[TBL] [Abstract][Full Text] [Related]
18. Impact of patterns of proteinuria on renal allograft function and survival: a prospective cohort study.
Suhail SM; Kee TS; Woo KT; Tan HK; Yang WS; Chan CM; Foo MW; Li HH; Siddique MM; Wong KS
Clin Transplant; 2011; 25(3):E297-303. PubMed ID: 21362048
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation.
Heinze G; Mitterbauer C; Regele H; Kramar R; Winkelmayer WC; Curhan GC; Oberbauer R
J Am Soc Nephrol; 2006 Mar; 17(3):889-99. PubMed ID: 16481415
[TBL] [Abstract][Full Text] [Related]
20. Clinical outcome of preemptive kidney transplantation in patients with diabetes mellitus.
Son YK; Oh JS; Kim SM; Jeon JM; Shin YH; Kim JK
Transplant Proc; 2010 Nov; 42(9):3497-502. PubMed ID: 21094803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
